XXI međunarodna konvencija o kvalitetu JUSK ICQ – 29 – 31. maj 2025, Beograd, (172-178 str.)
АУТОР(И) / AUTHOR(S): Jelena Marjanović 
Download Full Pdf 
DOI: 10.46793/XXIJUSK-ICQ.172M
САЖЕТАК / ABSTRACT:
Interferences such as hemolysis, icterus, and lipemia are relatively common in routine laboratory practice and can significantly affect the accuracy and precision of laboratory test results. Early detection and minimization of these interferences are essential for improving the quality and reliability of laboratory testing. One method for identifying interference is visual assessment, which is quick and cost-effective but inherently subjective and insufficiently accurate. In contrast, automated interference index measurement allows for faster and more precise identification of interferents in serum or plasma. Interference indices are used to generate both qualitative and quantitative assessments of the presence of hemolysis, icterus, or lipemia, enabling more reliable interpretation of interferences. This method supports laboratory personnel in making informed decisions regarding the handling of affected samples. Subsequent steps may include sample recollection, with holding of results affected by interference, or releasing results accompanied by an interpretative comment regarding the presence of interference and its potential impact on result accuracy.
КЉУЧНЕ РЕЧИ / KEYWORDS:
interference, hemolysis, icterus, lipemia, interference index, precision, accuracy
ПРОЈЕКАТ / ACKNOWLEDGEMENT:
ЛИТЕРАТУРА / REFERENCES:
- Cadamuro, J., Lippi, G., von Meyer, A., Ibarz, M., Dongen, van E., Cornes, M., Nybo, M., Vermeersch, P., Grankvist, K., Guimaraes, J.T., Kristensen, G., Salle, B., Simundic, A.M., European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE), Biochemia Medica, Vol. 29, No. 2, pp. 1 – 12, 2019.
- Ho, C.K.M., Chen, C., Setoh, J.W.S., Yap, W.W.T., Hawkins, R.C.W., Optimization of hemolysis, icterus and lipemia interference thresholds for 35 clinical chemistry assays, Practical Laboratory Medicine, Vol. 25, pp. 1 – 9, 2021.
- Farrell, C.J.L., Carter, A.C., Serum indices: managing assay interference, Annals of Clinical Biochemistry, Vol. 53, No. 5, pp 527-538, 2016.
- Karin, A., Higgins, V., Miller, J., Brinc, D., Kulasingam, V., Selvaratnam, R., Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays, Clinical Chemistry and Laboratory Medicine, Vol. 61, No. 6, pp. 1035 – 1045, 2023.
- Agarwal, S., Vargas, G., Nordstrom, C., Tam, E., Buffone, G. J., Devaraj, S., Effect of interference from hemolysis, icterus and lipemia on routine pediatric clinical chemistry assays, Clinica Chimica Acta, Vol. 438, pp. 241–245, 2015.
- Simundic, A.M., Baird, G., Cadamuro, J., Costelloe, S.J., Lippi, G., Managing hemolyzed samples in clinical laboratories, Critical Reviews in Clinical Laboratory Sciences, Vol. 57, No. 1, pp. 1-21, 2020.
- Hasanato, R., Brearton, S., Alshebani, M., Bailey, L., Aldugashim, S., Alothaim, A., Tamimi, W., Effects of serum indices interference on hormonal results from the Abbott Architect i2000 immunoassay analyser
- Lippi, G., Cadamuro, J., von Meyer, A., Simundic, A.M., Practical recommendations for managing hemolyzed samples in clinical chemistry testing, Clinical Chemistry and Laboratory Medicine, Vol. 56, No. 5, pp. 718-727, 2018.
